IRIS
FRANZONE, ANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.309
EU - Europa 798
AS - Asia 620
AF - Africa 49
OC - Oceania 2
SA - Sud America 1
Totale 2.779
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.284
IT - Italia 408
SG - Singapore 315
CN - Cina 274
NL - Olanda 165
FI - Finlandia 56
IE - Irlanda 56
CI - Costa d'Avorio 49
GB - Regno Unito 30
CA - Canada 25
DE - Germania 24
FR - Francia 21
VN - Vietnam 15
CZ - Repubblica Ceca 12
IN - India 8
BE - Belgio 7
CH - Svizzera 5
IR - Iran 5
SE - Svezia 4
RU - Federazione Russa 3
AT - Austria 2
ES - Italia 2
UA - Ucraina 2
AU - Australia 1
BR - Brasile 1
JP - Giappone 1
MK - Macedonia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
Totale 2.779
Salva come PNG Salva come JPEG
Città #
Singapore 257
Chandler 186
Amsterdam 155
Millbury 117
Ashburn 113
Naples 105
Nanjing 86
Princeton 81
Santa Clara 66
Beijing 57
Napoli 57
Des Moines 51
Boston 38
Wilmington 28
Nanchang 24
Ottawa 22
Hebei 17
Lawrence 16
Shenyang 15
Tianjin 14
Changsha 13
Dong Ket 13
Washington 13
Brno 12
Jacksonville 11
Kunming 11
Jiaxing 9
Kronberg 8
Lappeenranta 8
Torre del Greco 8
Augusta 7
Milan 7
Norwalk 7
Rome 7
San Mateo 6
Bern 5
Dallas 5
Pune 5
Redwood City 5
Sant'anastasia 5
Shanghai 5
Brussels 4
Council Bluffs 4
Florence 4
Helsinki 4
London 4
San Giuseppe Vesuviano 4
Seattle 4
Villaricca 4
Ann Arbor 3
Canary Wharf 3
Dublin 3
Giugliano in Campania 3
League City 3
Leawood 3
Marsala 3
Redmond 3
Sunnyvale 3
Tehran 3
Toronto 3
Trecase 3
Woodbridge 3
Ardabil 2
Baltimore 2
Baranzate 2
Capua 2
Casavatore 2
Caserta 2
Catania 2
Changchun 2
Courcelles 2
Eboli 2
Fairfield 2
Fremont 2
Hangzhou 2
Ho Chi Minh City 2
Houston 2
Leipzig 2
Mugnano di Napoli 2
Munich 2
Nocera Superiore 2
Piedimonte 2
Reggio Emilia 2
Saint-Fons 2
San Mango Piemonte 2
Solofra 2
Stella Cilento 2
The Dalles 2
Vienna 2
West Jordan 2
Angri 1
Arezzo 1
Aurisina Cave 1
Avellino 1
Aversa 1
Bacoli 1
Bagheria 1
Battipaglia 1
Bengaluru 1
Bitola 1
Totale 1.812
Salva come PNG Salva come JPEG
Nome #
Akap1 Regulates Vascular Function and Endothelial Cells Behavior 80
Dermcidin: a skeletal muscle myokine modulating cardiomyocyte survival and infarct size after coronary artery ligation 58
Meta-Analysis of Mortality Outcomes and Mitral Regurgitation Evolution in 4,839 Patients Having Transcatheter Aortic Valve Implantation for Severe Aortic Stenosis. 56
Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis 56
Loss of Akap1 exacerbates pressure overload-induced cardiac hypertrophy and heart failure 56
Contemporary use and results of intra-aortic balloon pump counterpulsation. 51
ADDED Index or percentage diameter of residual coronary stenosis to risk-stratify patients presenting with STEMI 49
IDENTIFICAZIONE PROTEOMICA DI UN NUOVO FATTORE COINVOLTO NELLA MODULAZIONE MOLECOLARE DEL RIMODELLAMENTO CARDIACO POST-ISCHEMICO NELL'ISCHEMIA CRONICA DEGLI ARTI INFERIORI. 48
ATHERECTOMY AS ALTERNATIVE ENDOVASCULAR THERAPY FOR INFRAINGUINAL ARTERY DISEASE. 46
Ankle/brachial index to everyone. 43
Pharmacodynamic effects of cangrelor in elective complex PCI: insights from the POMPEII Registry 41
Effects of Successful Percutaneous Lower Extremity Revascularization on Cardiovascular Outcome in Patients with Peripheral Arterial Disease 41
Bioabsorbable drug-eluting vascular scaffold for the treatment of coronary in-stent restenosis: A two center registry 41
Effects of Carvedilol Versus Metoprolol on Platelet Aggregation in Patients With Acute Coronary Syndrome: The PLATE-BLOCK Study 40
Adverse Post-Ischemic Cardiac Remodeling in Chronic Hindlimb Ischemia: Proteomic Identification of a Novel Molecular Mechanism 39
Extent of cardiac damage and mortality in patients undergoing transcatheter aortic valve implantation 39
Infectious endocarditis after transcatheter aortic valve implantation in a patient on oral therapy with glucocorticoids 38
Bioresorbable vascular scaffold implantation for the treatment of coronary in-stent restenosis: results from a multicenter Italian experience 37
Renal sympathetic-nerve ablation for uncontrolled hypertension in a patient with single-kidney autosomal dominant polycystic kidney disease. 37
Arterial hypertension in aortic valve stenosis: A critical update 36
Circulating miR-29a, Among Other Upregulated microRNAs, is the Only Biomarker for Both Hypertrophy and Fibrosis in Patients with Hypertrophic Cardiomyopathy. 35
Novel Molecular Approaches in Heart Failure: Seven Trans-Membrane Receptors Signaling in the Heart and Circulating Blood Leukocytes 35
Biodegradable-Polymer Sirolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in Patients with Acute ST-Segment Elevation Myocardial Infarction: Insights from the 2-Year Follow-Up of the BIOSCIENCE Trial 35
Predictors of adherence to composite therapy after acute coronary syndromes 35
Genetic deletion of uncoupling protein 3 exaggerates apoptotic cell death in the ischemic heart leading to heart failure 34
Left ventricular diastolic gradient in hypertrophic cardiomyopathy 34
L’IMPIANTO DI STENT NELLE ARTERIE DEGLI ARTI INFERIORI RIDUCE IL RISCHIO CARDIOVASCOLARE IN PAZIENTI CON ATEROSCLEROSI PLURIDISTRETTUALE. 33
Cardioprotective role of Urotensin (UT II)- mediated transactivation of the EGFR. 33
Cardiovascular effects of treadmill exercise in physiological and pathological preclinical settings. 33
Coronary angioplasty with stenting for acute coronary syndrome in patients with isolated single coronary artery: a report of two cases 33
Biological effects of statins in atherosclerosis 33
Angiographic complexity of coronary artery disease according to syntax score and clinical outcomes after revascularisation with newer-generation drug-eluting stents: A substudy of the bioscience trial 33
Coronary artery disease and myocardial revascularization in patients undergoing transcatheter aortic valve replacement 33
RUOLO DELL’UNCOUPLING PROTEIN 3 IN CONDIZIONI IPOSSICO-ISCHEMICHE 32
Endovascular repair for isolated iliac artery aneurysms: case report and review of the current literature. 31
Induction of mitogen activated protein kinases in response to pressure overload: a novel possible biomarker for uncontrolled human hypertension. 30
Effects of pressure unloading on mitogen-activated protein kinases in peripheral blood mononuclear cells of patients undergoing trans-catheter aortic valve implantation. 30
The Conundrum of Permanent Pacemaker Implantation after Transcatheter Aortic Valve Implantation 29
SAFETY AND EFFICACY OF OUBACK CATHETER-ASSISTED SUBINTIMAL RECANALIZATION OF TOTAL CHRONIC ILIAC ARTERY OCCLUSION. 28
The circulating level of FABP3is an indirect biomarker of microRNA-1. 28
Il ruolo del danno ischemico remoto permanente sul rimodellamento ventricolare post-IMA 27
Il ruolo del danno ischemico remoto permanente sul rimodellamento ventricolare post-IMA 27
Gβγ-dependent transactivation of the epidermal growth factor receptor by the Urotensin-II receptor. 27
RUOLO PROTETTIVO DELL'UNCOUPLING PROTEIN 3 (UCP3) NELLA MALATTIA ISCHEMICA. 27
De-Activation of Mitogen-Activated Protein Kinases in Peripheral Blood Mononuclear Cells of Patients Undergoing Trans-Catheter Aortic Valve Implantation. 27
From biodegradable polymers to bioresorbable vascular scaffolds: available evidence in the current era of new-generation DES 27
Clinical outcomes according to diabetic status in patients treated with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents: Prespecified subgroup analysis of the BIOSCIENCE trial 27
Induction of mitogen-activated protein kinases is proportional to the amount of pressure overload. 26
La modulazione molecolare del rimodellamento cardiaco post-ischemico nell'ischemia cronica degli arti inferiori. 26
Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantation 25
Molecular modulation of post-ischemic cardiac remodeling by hindlimb ischemia 25
Stent implantation in the arteries of the lower limbs reduces cardiovascular risk in peripheral arterial disease. 24
Nuovi concetti nella segnalazione beta-adrenergica: prospettive terapeutiche per lo scompenso cardiaco.. [Novel concepts in beta-adrenergic receptor signaling: therapeutic options for heart failure]. 24
Il secondo messaggero cAMP e la regolazione della funzione cardiaca: ruolo dell'adenilato ciclasi. 24
Use of the dual-antiplatelet therapy score to guide treatment duration after percutaneous coronary intervention 24
Platelet Inhibition with Ticagrelor 60 mg Versus 90 mg Twice Daily in Elderly Patients with Acute Coronary Syndrome: Rationale and Design of the PLINY THE ELDER Trial 24
Myocardial mass affects diagnostic performance of non-hyperemic pressure-derived indexes in the assessment of coronary stenosis 23
One-Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus-Eluting Stents in High Bleeding Risk Patients 22
Rotational atherectomy for the treatment of isolated femoral artery traumatic lesion: A case report 22
Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: The GLOBAL LEADERS Adjudication Sub-StudY (GLASSY) 22
Comparative effectiveness and safety of new-generation versus early-generation drug-eluting stents according to complexity of coronary artery disease: A patient-level pooled analysis of 6,081 patients 21
Double layered stents for carotid angioplasty: A meta-analysis of available clinical data 20
Coronary artery disease in patients hospitalised with Coronavirus disease 2019 (COVID-19) infection 20
EGFR Trans-activation by Urotensin II Receptor is Mediated by Beta-arrestin Recruitment and Confers Cardioprotection in Pressure Overload-induced Cardiac Hypertrophy. 19
Mortality after Bleeding versus Myocardial Infarction in Coronary Artery Disease: A Systematic Review and Meta-Analysis 19
Clinical and hemodynamic performance of the ACURATE neo bioprosthesis: Looking far and beyond randomized trials 19
Impact of COVID-19 pandemic on timing and early clinical outcomes of transcatheter aortic valve implantation 18
Impact of Sex on 2-Year Clinical Outcomes in Patients Treated With 6-Month or 24-Month Dual-Antiplatelet Therapy Duration: A Pre-Specified Analysis From the PRODIGY Trial 18
Impact of chronic kidney disease on 2-year clinical outcomes in patients treated with 6-month or 24-month DAPT duration: An analysis from the PRODIGY trial 18
Patent foramen ovale closure vs. medical therapy for recurrent stroke prevention: Evolution of treatment effect during follow-up 18
[Updated SICI-GISE position paper on institutional and operator requirements for transcatheter aortic valve implantation] 18
Periprocedural myocardial infarction in patients undergoing complex versus noncomplex percutaneous coronary intervention 17
Antithrombotic Therapy in Peripheral Artery Disease: Current Evidence and Future Directions 17
Incidence and impact of renal dysfunction on clinical outcomes after transcatheter aortic valve implantation 17
A randomized multicenter trial comparing the XIENCE everolimus eluting stent with the CYPHER sirolimus eluting stent in the treatment of female patients with de novo coronary artery lesions: The SPIRIT WOMEN study 17
Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable-polymer everolimus-eluting stent for percutaneous coronary revascularization: 2-year results of the BIOSCIENCE trial 17
Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting 17
From bare metal to barely anything: An update on coronary stenting 16
Management of in-stent restenosis in peripheral arteries: are DEBs sufficient as stand-alone treatment for femoro-popliteal in-stent restenosis? 16
The impact of functional vs degenerative mitral regurgitation on clinical outcomes among patients undergoing transcatheter aortic valve implantation 16
Prolonged vs short duration of dual antiplatelet therapy after percutaneous coronary intervention in patients with or without peripheral arterial disease: A subgroup analysis of the PRODIGY randomized clinical trial 16
Prognostic Relevance of Left Ventricular Myocardial Performance After Transcatheter Aortic Valve Replacement 16
The role of atherectomy in the treatment of lower extremity peripheral artery disease. 15
Effects of coronary artery disease in patients undergoing transcatheter aortic valve implantation: A study of age- and gender-matched cohorts 15
Transcatheter Aortic Valve Replacement for the Treatment of Pure Native Aortic Valve Regurgitation: A Systematic Review 15
Incidence, predictors, and prognostic impact of temporary left bundle branch block after transcatheter aortic valve replacement 14
CT Coronary Angiography: Technical Approach and Atherosclerotic Plaque Characterization 14
Management of Non-Culprit Lesions in STEMI Patients with Multivessel Disease 14
MODULAZIONE MOLECOLARE DEL RIMODELLAMENTO CARDIACO POST-ISCHEMICO NELL'ISCHEMIA CRONICA DEGLI ARTI INFERIORI. 14
null 14
Prognostic impact of invasive haemodynamic measurements in combination with clinical and echocardiographic characteristics on two-year clinical outcomes of patients undergoing transcatheter aortic valve implantation 14
Radial versus femoral approach in STEMI: What do we know so far? 14
Prognostic Value of Right Ventricular Dysfunction on Clinical Outcomes After Transcatheter Aortic Valve Replacement 14
Frequency, Timing, and Impact of Access-Site and Non–Access-Site Bleeding on Mortality Among Patients Undergoing Transcatheter Aortic Valve Replacement 14
Impact of diabetic status on outcomes after revascularization with drug-eluting stents in relation to coronary artery disease complexity: Patient-level pooled analysis of 6081 patients 13
Effect of Diabetes Mellitus on Frequency of Adverse Events in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention 13
External validity of the “all-comers” design: insights from the BIOSCIENCE trial 13
Early versus newer generation devices for transcatheter aortic valve implantation in routine clinical practice: A propensity score matched analysis 13
Acute advanced aortic stenosis 13
Ticagrelor alone or conventional dual antiplatelet therapy in patients with stable or acute coronary syndromes 12
Totale 2.717
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.574
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.574
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020118 0 0 0 0 9 2 7 2 11 39 38 10
2020/2021137 2 1 9 2 1 22 3 11 32 1 40 13
2021/2022472 11 0 2 1 13 9 4 24 74 31 80 223
2022/2023648 99 43 25 27 59 54 11 34 83 157 38 18
2023/2024665 20 94 90 62 35 71 25 66 24 17 94 67
2024/2025421 153 147 16 36 69 0 0 0 0 0 0 0
Totale 2.972